锦欣生殖(01951)12月15日斥资993.9万港元回购389.1万股
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 15, 2025, involving an expenditure of HKD 9.939 million to repurchase 3.891 million shares [1]
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 15, 2025, involving an expenditure of HKD 9.939 million to repurchase 3.891 million shares [1]